AFLD 2011 FFF vs Respondent M04

Facts
The French Football Federation (Fédération Française de Football, FFF) charges respondent M04 for a violation of the Anti-Doping Rules. During a match on June 20, 2010, a sample was taken for doping control purposes. The analysis showed the presence of tuaminoheptane. Tuaminohetane is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The cause of the positive test was medication the respondent used to treat a cold. The medication is freely available in all drugstores.

Decision
1. The sanction is a period of ineligibility of one month in which respondent can't take part in competitions and sporting events organized or authorized by the FFF.
2. The period of ineligibility will be reduced by the period already served by the earlier decision, dated September 15, 2010, of the disciplinary committee of the FFF.
3. The earlier decision dated September 15, 2010, of the disciplinary committee of the FFF will not be modified.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
6 January 2011
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
Football (FIFA) - International Football Federation
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Football (FFF) - French Football Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S6. Stimulants
Substances
Tuaminoheptane
Medical terms
Treatment / self-medication
Document type
Pdf file
Date generated
11 March 2014
Date of last modification
13 March 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin